* Applied Molecular Transport Inc. AMTI.OQ AMTI.O is
expected
to show no change in quarterly revenue when it reports
results on May 11 (estimated).
* Refinitiv's mean analyst estimate for Applied Molecular
Transport Inc. is for a loss of 75 cents per share. For the same
quarter last year, the company reported a loss of 58 cents per
share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Applied
Molecular
Transport Inc. is $74, above its last closing price of $4.45.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 -0.66 -0.66 -0.78 Missed -17.6
Sep. 30 2021 -0.61 -0.62 -0.68 Missed -9.7
Jun. 30 2021 -0.59 -0.60 -0.62 Missed -3.3
Mar. 31 2021 -0.75 -0.75 -0.58 Beat 22.7
Dec. -0.51 -0.47 -0.38 Beat 20
31 2020
Sep. 30 2020 -0.41 -0.41 -0.48 Missed -17.1
Jun. 30 2020 -0.38 -0.38 -1.11 Missed -192.1
This summary was machine generated May 9 at 11:00 GMT. All
figures in US dollars unless otherwise stated